Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 7 Issue 7

Packaging Challenge for COVID-19 Drug

Anupam Chanda*

Post Graduate from IIP, Mumbai, India and Bioxytran. Inc, Boston, MA, USA

*Corresponding Author: Anupam Chanda, Post Graduate from IIP, Mumbai, India and Bioxytran. Inc, Boston, MA, USA.

Received: April 21, 2020; Published: June 26, 2023


At present Corona virus is the most burning topic across the world and approximately 100000 people already died, 50000 are on the way and more than 2 million people got effected with this deadly virus. At present there is no drug available to cure 100%. So many companies are trying to make it possible as soon as they can. The basic characteristics of the product is “Non-Toxic made of sugars carbohydrates”. A galectin is a protein that recognizes carbohydrates and modulates intracellular and extracellular interactions primarily related to the immune system. In some cases galectins act as a glue bringing molecules together. The major focus of the research is on extracellular interactions. Galectins have emerged as amplifiers or silencers of inflammatory responses, capable of orchestrating complex regulatory circuits in innate and adaptive immune cells, as well as in synovial fibroblasts. Galectins are responsible for T-cell energy and prevent LFA-1 lectins (depicted in blue) from coalescing and adhering to the target cell in order to destroy it with cytotoxins.


  4. Highlights from June 2011 Glass Container Delamination Scientific Symposium (2013).
  5. Swift, Rob Amgen presentations, PDA April 2011 San Antonio; PDA/FDA Glass Quality Conference May (2011).
  7. Ennis., et al. Pharmaceutical Development and Technology 6.3 (2001): 393-405.
  8. Hunt, Desmond, USP Presentation, PDA/FDA Glass Quality Conference May (2013).


Citation: Anupam Chanda. “Packaging Challenge for COVID-19 Drug". Acta Scientific Pharmaceutical Sciences 7.7 (2023): 43-53.


Copyright: © 2023 Anupam Chanda. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US